Nanotechnology

Nanoparticle Engineering

The value in applying AI in Pharma is in making new and better drugs available faster than would be possible otherwise. By augmenting sparse-data AI with expert knowledge and applying it to the latest nanoparticle engineering techniques, opportunities are created to eliminate the risk associated with new techniques and give therapeutics a second chance to reach the patients who need them.

Nanoforming

In 2019, the pharmaceutical industry invested $182 billion in drug development, but only 48 drugs were approved for use.

Trend Barometer of Specialty Chemicals Industry

China’s Investors Advance

Camelot’s Pharma Management Radar

Lubrizol Takes Daelim License for US Polyisobutylenes Plant

NanoInnovation: What Every Manager Needs to Know

Germany’s Merck Adds Israeli R&D Partners

AkzoNobel Science Award Honors Two Swedish Professors

Big Drugmakers Think Small with Nanomedicine Deals

AstraZeneca Bets on Nanotech with Bind Therapeutics Deal

GSK Plans $1 Million Prize to Jump-start "Electroceuticals"

Twaron Spinning Process for Carbon Nanotube Fibers

Queen's Develops Environmentally Friendly MOF Production Method

Communicating Nanomaterials

Steptoe & Johnson: Nanomaterials Need Effective Risk Governance

Labeling Nano-Products

Winning Back Trace Elements

Winning Back Trace Elements